Zepbound
Entity.
- Evidence
- 71 documents · 30 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 29 Oct 2026
- Measured
- 1% of mentions say something specific about it; the rest only name it
- As of
- 29 Oct 2026
Where this comes from
- Clinical Trials Arena · 2026-10-12 · Lilly reports Phase IIIb data on Taltz and Zepbound combination (opens the source in a new tab)
- 24/7 Wall St. · 2026-10-07 · Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound (opens the source in a new tab)
- Medical Daily · 2026-10-03 · Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss (opens the source in a new tab)
- Business Model Analyst · 2026-10-02 · Lilly’s New Obesity Combo Beat Zepbound With a Third of the Zepbound (opens the source in a new tab)
- STAT News · 2026-10-01 · STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial (opens the source in a new tab)
- Latest Science News -- ScienceDaily · 2026-09-27 · Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat (opens the source in a new tab)